GET THE APP

Medical expulsive therapy for ureteric stones: Analyzing the evidence from systematic reviews and meta-analysis of powered double-blinded randomised controlled trials
..

Journal of Nephrology & Therapeutics

ISSN: 2161-0959

Open Access

Medical expulsive therapy for ureteric stones: Analyzing the evidence from systematic reviews and meta-analysis of powered double-blinded randomised controlled trials


19th Global Nephrologists Annual Meeting

May 14-15, 2018 | Rome, Italy

Banan Abbas Mustafa Osman

Bristol Urological Institute, UK
Severn Major Trauma Network, UK

Scientific Tracks Abstracts: J Nephrol Ther

Abstract :

Urinary tract stones affect 1â??15% of the general population and the incidence is on the rise. Annual costs for stone disease have rapidly increased over the years and most patients with ureteral colic or other symptoms seek medical care. This has led to a plethora of research into the field aiming at finding a medication that will increase stone passage, shorten time to passage, and alleviate pain. The role of medical expulsive therapy (MET) is debatable with studies showing benefit for medical expulsive therapy (MET), whilst others reported no benefit. However, despite the multitude of trials published, the debate remains, as most of the research is riddled with bias and confounding factors. We therefore conducted a Cochrane style systematic review and a pooled meta-analysis on published literature from 1990 to 2016, to include low risk of bias (RoB) randomised controlled trials (RCTs) and a power calculation to investigate the efficacy and safety of medical expulsive therapy (MET). Pooled analysis of powered RCTs with low RoB would suggest, MET with the use of an a-blocker does increase stone expulsion rates (a-blockers 78% vs. 71% control) (P<0.001). Furthermore, their role is more significant for larger (>5 mm) stones (a-blockers 75% vs. 61% control) (P=0.02) and stones in the lower ureter (a-blockers 83% vs. 72% control) (P<0.001). However, MET was associated with side-effects, albeit not severe.

Biography :

Banan Abbas Mustafa Osman is a British urology trainee joined University of Medical Science and Technology. She is an Honorary Clinical Tutor for the Severn School of Surgery. She is also a teaching faculty member at Royal College of Surgeons England. She was appointed annually over three years as a Surgical and Urology trainee representative in Junior’s Doctor’s Forum in the Royal Marsden NHS Foundation Trust & North Bristol NHS Trust. She was a Clinical Investigator in VORTEX Clinical Trial. She held a position of Assistant Director of training in SMA International Training School.
Email:banan_abbas@yahoo.co.uk

Google Scholar citation report
Citations: 784

Journal of Nephrology & Therapeutics received 784 citations as per Google Scholar report

Journal of Nephrology & Therapeutics peer review process verified at publons

Indexed In

 
arrow_upward arrow_upward